EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Villalón, A. L.
Right arrow Articles by Diéguez, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Villalón, A. L.
Right arrow Articles by Diéguez, G.
Experimental Biology and Medicine 229:118-120 (2004)
© 2004 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Urocortin Protects Coronary Endothelial Function During Ischemia-Reperfusion: A Brief Communication

Angel Luis García-Villalón1, Elena Sanz, Luis Monge, Nuria Fernández, Belén Climent and Godofredo Diéguez

Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma, 28029 Madrid, Spain

To whom requests for reprints should be addressed at 1 Departamento de Fisiología, Facultad de Medicina, Universidad Autonoma, Arzobispo Morcillo 2, 28029 Madrid, Spain. E-mail: angeluis.villalon{at}uam.es

Urocortin is a vasodilator peptide related to corticotrophin-releasing factor, which may protect myocardium during coronary ischemia-reperfusion. To study whether urocortin also protects coronary endothelial function during ischemia-reperfusion, hearts from Sprague-Dawley rats were perfused at constant flow and then exposed to 15 mins ischemia followed by 15 mins reperfusion. In one series of experiments, we found that the coronary relaxation to urocortin (10-11 to 10-8 M) was reduced by ischemia-reperfusion (51 ± 4% vs. 79 ± 4% of the active tone, for the 10-10 Mdose). In other series of experiments, we observed that ischemia-reperfusion reduced the coronary relaxation to a test dose of acetylcholine (10-6 M) (25 ± 2% vs. 54 ± 9% of active tone), without modifying the relaxation to sodium nitroprusside (10-6 M). Treatment with a low threshold concentration of urocortin (10-11 M), administered before ischemia and during reperfusion, partly improved the coronary relaxation to acetylcholine (36 ± 3% of active tone). These results suggest that ischemia-reperfusion impairs the coronary vasodilation to urocortin and produces endothelial dysfunction and that this endothelial dysfunction may be improved by urocortin.

Key Words: acetylcholine • heart • Langendorff • sodium nitroprusside




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
H. Tu, A. J. Kastin, and W. Pan
Corticotropin-Releasing Hormone Receptor (CRHR)1 and CRHR2 Are Both Trafficking and Signaling Receptors for Urocortin
Mol. Endocrinol., March 1, 2007; 21(3): 700 - 711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Experimental Biology and Medicine.